(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 7.48% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.8%.
Treace Medical Concepts's revenue in 2025 is $213,751,000.On average, 3 Wall Street analysts forecast TMCI's revenue for 2025 to be $14,346,616,915, with the lowest TMCI revenue forecast at $14,340,299,602, and the highest TMCI revenue forecast at $14,355,461,152. On average, 3 Wall Street analysts forecast TMCI's revenue for 2026 to be $15,626,062,235, with the lowest TMCI revenue forecast at $15,536,798,608, and the highest TMCI revenue forecast at $15,775,593,025.
In 2027, TMCI is forecast to generate $16,820,666,048 in revenue, with the lowest revenue forecast at $16,736,456,271 and the highest revenue forecast at $16,965,774,719.